New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 18, 2012
10:00 EDTPJC, EIX, QUAD, SYK, SWK, STJ, SKUL, RDS.A, POT, HAL, DB, CMA, CSX, ABTOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abbott (ABT) downgraded to Market Perform from Outperform at Raymond James... CSX (CSX) downgraded to Hold from Buy at Deutsche Bank... Comerica (CMA) downgraded to Neutral from Buy at Sterne Agee... Deutsche Bank (DB) downgraded to Underweight from Neutral at JPMorgan... Halliburton (HAL) downgraded to Equal Weight from Overweight at Stephens... Potash (POT) downgraded to Sector Perform from Outperform at RBC Capital... Royal Dutch Shell (RDS.A) downgraded to Sell from Neutral at Goldman... Skullcandy (SKUL) downgraded to Market Perform from Strong Buy at Raymond James... St. Jude Medical (STJ) downgraded to Hold from Buy at Canaccord...Stanley Black & Decker (SWK) downgraded to Market Perform from Outperform at Raymond James... Stryker (SYK) downgraded to Perform from Outperform at Oppenheimer... Quad/Graphics (QUAD) downgraded to Underperform at Sector Perform at RBC Capital... Edison International (EIX) downgraded to Neutral from Buy at Citigroup... Piper Jaffray (PJC) downgraded to Hold from Buy at Sandler O'Neill.
News For A;SKUL;STJ;SWK;SYK;QUAD;EIX;PJC From The Last 14 Days
Check below for free stories on A;SKUL;STJ;SWK;SYK;QUAD;EIX;PJC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 28, 2014
09:44 EDTSWK, SWKStanley Black & Decker downgraded to Outperform from Buy at CLSA (pre-open)
Subscribe for More Information
July 25, 2014
10:02 EDTEIXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:23 EDTEIXEdison International upgraded to Buy from Hold at Argus
Argus upgraded Edison International to Buy based on valuation, strong cash flow, the retirement of the San Onofre nuclear plan and is positive that the loss-ridden Edison Mission Energy business is not longer part of the portfolio. Price target is $65.
06:03 EDTSWKStanley Black & Decker raises FY14 adjusted EPS to $5.50-$5.60 from $5.35-$5.50
Subscribe for More Information
06:01 EDTSWKStanley Black & Decker reports Q2 adjusted EPS $1.43, consensus $1.37
Reports Q2 revenue $2.89B, consensus $2.94B
July 24, 2014
11:01 EDTAAgilent signs co-marketing agreement with MRM Proteomics
Subscribe for More Information
08:19 EDTSYKLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:10 EDTPJCPiper Jaffray reports Q2 adjusted EPS $1.25, consensus $1.18
Subscribe for More Information
July 23, 2014
13:36 EDTSYKIntuitive Surgical rises after Q2 EPS, revenue beat expectations
Subscribe for More Information
11:53 EDTSWKStanley Black & Decker board increases dividend by 2c to 52c
Subscribe for More Information
07:45 EDTSTJSt. Jude Medical management to meet with Deutsche Bank
Subscribe for More Information
July 22, 2014
16:04 EDTSKULSkullcandy names David Raffone as Chief Sales and Revenue Officer
Subscribe for More Information
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
08:02 EDTSTJSt. Jude announces FlexAbility Ablation Catheter CE Mark approval, first use
St. Jude Medical CE Mark approval and first use of the FlexAbility Ablation Catheter. Designed with feedback from physician thought-leaders around the world, the FlexAbility catheter combines a unique, irrigated flexible catheter tip with a state-of-the-art handle and catheter design. The next-generation flexible tip technology was designed to reduce complications associated with ablation procedures through its ability to bend and conform to the cardiac anatomy, decreasing the amount of pressure distributed to a patientís heart wall while simultaneously increasing the stability of therapy delivery.
July 18, 2014
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.
July 17, 2014
16:09 EDTSYKStryker sees Q3 adjusted EPS $1.12-$1.16 , consensus $1.16
"If foreign currency exchange rates hold near current levels, we do not expect the impact on third quarter or full year net sales to be significant," the company said.
16:08 EDTSYKStryker sees FY14 adjusted EPS $4.75-$4.80, consensus $4.80
Now projecting full year organic sales growth to be in the range of 5.0%-6.0%, consensus $9.61B.
16:07 EDTSYKStryker reports Q2 adjusted EPS $1.08, consensus $1.08
Subscribe for More Information
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
06:20 EDTAAgilent initiated with a Neutral at Citigroup
Target $64.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use